Cord Blood Stem Cells Information - Molecular Medicine News

Molecular Medicine News

Scientists shed new light into early mechanisms governing cardiovascular specification Thursday, July 3, 2008 @ 6:17PMThe mature heart is composed by different cell types, including contractile cardiac cells, vascular cells, smooth muscle cells as well as pacemaker cells.
Researchers Are First To Simulate The Binding Of Molecules To A Protein Thursday, July 3, 2008 @ 5:21PMYou may not know what it is, but you burn more than your body weight of it every day. Adenosine triphosphate, a tiny molecule that packs a powerful punch, is the primary energy source for most of your cellular functions. Now researchers have identified a key step in the cellular recycling of ATP that allows your body to produce enough of it to survive.
Introgen Reduces Development Staff to Focus on Commercial Activities after ADVEXIN Regulatory Filings in U.S. and Europe Thursday, July 3, 2008 @ 4:48PMIntrogen Therapeutics, Inc. (NASDAQ:INGN) today announced a re-allocation of employees to focus on regulatory review and commercial activities. After years of product development, Introgen is directing corporate spending toward regulatory review programs, commercialization and the future marketing of ADVEXIN therapy. Recently the Company achieved the major corporate milestone of filing for ...
Introgen Reduces Development Staff to Focus on Commercial Activities after ADVEXIN Regulatory Filings in U.S. and Europe Thursday, July 3, 2008 @ 4:45PMIntrogen Therapeutics, Inc. (NASDAQ:INGN) today announced a re-allocation of employees to focus on regulatory review and commercial activities. After years of product development, Introgen is directing corporate spending toward regulatory ...
Introgen Reduces Development Staff to Focus on Commercial Activities after ADVEXIN Regulatory Filings in U.S. and Europe Thursday, July 3, 2008 @ 4:45PMIntrogen Therapeutics, Inc. (7783;NASDAQ:INGN) today announced a re-allocation of employees to focus on
Introgen Reduces Development Staff to Focus on Commercial Activities after ADVEXIN Regulatory Filings in U.S. and Europe Thursday, July 3, 2008 @ 4:30PM AUSTIN, Texas----Introgen Therapeutics, Inc. today announced a re-allocation of employees to focus on regulatory review and commercial activities. After years of product development, Introgen is directing corporate spending toward regulatory review programs, commercialization and the future marketing of ADVEXIN therapy.
Discovery Of Gene Mechanism Could Bring About New Ways To Treat Metastatic Cancer Thursday, July 3, 2008 @ 1:21PMThe molecular and biochemical mechanism of action of unique cytokine gene found to induce potent bystander antitumor effects in animal models and in Phase I clinical trials has been identified. Researchers have uncovered how a gene, melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that kills cancer cells not directly receiving mda-7/IL-24 ...
Common drugs may combat aging disease Thursday, July 3, 2008 @ 12:12PMTwo drugs used to treat cholesterol and osteoporosis have reversed the effects of progeria, a premature ageing disease, in mice
Tumor Suppressor That Manages Cellular Cleaning And Recycling Proceses Identified Thursday, July 3, 2008 @ 11:20AMResearchers have identified a specific tumor suppressor that manages membrane traffic routes for cellular cleaning and recycling.
In print Thursday, July 3, 2008 @ 11:14AMA substance found in red wine and touted as the chemical equivalent of the fountain of youth probably acts more like a wellspring of health — with warning signs.
Blood vessel inhibitor shows promise against metastatic thyroid cancer Thursday, July 3, 2008 @ 10:39AMThyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.
Researchers identify tumor suppressor that manages cellular cleaning and recycling proceses Thursday, July 3, 2008 @ 10:38AMResearchers at the University of Southern California (USC) have identified a specific tumor suppressor that manages membrane traffic routes for cellular cleaning and recycling.
BioTrove, Gene Express Awarded NIH Grant To Develop Novel Standardized Genetic Profiling Test Thursday, July 3, 2008 @ 8:13AMBioTrove, Inc. and Gene Express, Inc. announced their receipt of a two-year National Institutes of Health (NIH) grant, awarded in support of their proposed novel research of genetic biomarkers for lung cancer.
OSI Pharmaceuticals Announces Conversion Period for Convertible Notes Thursday, July 3, 2008 @ 8:02AMOSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its 2% Convertible Senior Notes due 2025 (the "notes") are now convertible at the option of the holders and will remain convertible through September 30, 2008, the last trading day of the current fiscal quarter, as provided for in the Indenture governing the notes.
OSI Pharmaceuticals Announces Conversion Period for Convertible Notes Thursday, July 3, 2008 @ 7:40AMOSI Pharmaceuticals Announces Conversion Period for Convertible Notes
Researchers Identify Tumor Suppressor That Manages Cellular Cleaning And Recycling Processes Wednesday, July 2, 2008 @ 9:18PMResearchers at the University of Southern California (USC) have identified a specific tumor suppressor that manages membrane traffic routes for cellular cleaning and recycling.
Line-up Of AJR Editors Expanded To Meet The Needs Of Changing Profession Wednesday, July 2, 2008 @ 7:12PMThe July issue if the American Journal of Roentgenology marks the official debut of new editor-in-chief, Thomas H. Berquist, MD of the Mayo Clinic College of Medicine in Jacksonville, FL. Beginning with this issue, Dr. Berquist has created a new level of editors for the AJR.
EARLY RELEASE: Detection of Mutations in EGFR in Circulating Lung-Cancer Cells Wednesday, July 2, 2008 @ 4:31PM Background The use of tyrosine kinase inhibitors to target the epidermal growth factor receptor gene (EGFR) in patients with non-small-cell lung cancer is effective but limited by the emergence of ...
Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer Wednesday, July 2, 2008 @ 4:18PMThyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.
Evaluating a new MDR-TB test Wednesday, July 2, 2008 @ 2:21PMIf patients failing to complete the treatment, and wrong medication by the medical practitioners often leads to drug resistance in TB patients, diagnosing people who are resistant to the first-line drugs is fraught with long ...
Common drugs offer aging disease hope Wednesday, July 2, 2008 @ 12:24PMTwo drugs used to treat cholesterol and osteoporosis have reversed the effects of progeria, a premature ageing disease, in mice
Key Challenges and Issues facing the World Immunoassay Instruments Market Wednesday, July 2, 2008 @ 12:10PM Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
Protein that may make more bone and reduce fat identified Wednesday, July 2, 2008 @ 11:13AMWashington, July 2 : Researchers from Medical College of Georgia Institute of Molecular Medicine and Genetics have identified a protein that may make more bone and reduce fat.
Pulmo BioTech Inc. Announces Possibility of MRI Application for PulmoBind Wednesday, July 2, 2008 @ 10:25AM Pulmo BioTech Inc. has announced the possibility of a new application for its PulmoBind Molecular Imaging technology.
Dividing Cells Find Their Middle by Following Protein Contour Map Monday, June 30, 2008 @ 3:15PMScientists at Rockefeller University have shown that a protein-chemistry-based contour map, which helps individual proteins locate the center of their cell without direction from a "master organizer," is key to ensuring accurate division during mitosis.
Integrins as receptors give insight into rotavirus and diarrhea Monday, June 30, 2008 @ 10:57AMEleven years ago, Dr. Mary Estes of Baylor College of Medicine and her colleagues discovered the first viral enterotoxin, rotavirus NSP4, a toxic protein that affects the intestines, causing diarrhea.
DuPont Gives Grants to Young Professors Developing Novel Science of Company Interest Monday, June 30, 2008 @ 10:00AM DuPont today recognized 17 young professors from universities in the United States, China, Spain and India with the annual DuPont Young Professor grant.
Covidien Appoints New Research & Development Executives in Its Pharmaceutical and Imaging Businesses Monday, June 30, 2008 @ 9:02AMCovidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the appointment of the research and development (R&D) leadership team for its Pharmaceutical Products and Imaging Solutions businesses.
Students in the News Sunday, June 29, 2008 @ 6:55AMERIE - Michael Sobolewski, of Erie, graduated June 1 from the Lake Erie College of Osteopathic Medicine.
Weighing the Costs of a CT Scan’s Look Inside the Heart Sunday, June 29, 2008 @ 2:37AM Driven by financial incentives, many doctors are adopting CT scans, but there is scant evidence that they benefit most patients.
Oklahoma State lists graduates for spring 2008 semester Saturday, June 28, 2008 @ 11:54PMA total of 2,608 students representing 42 states and numerous countries were awarded degrees from Oklahoma State University in Stillwater at the end of the 2008 spring session, according to the Office of the Registrar.
Genome Communication: Alleles Of Homologous Genes Can Silence One Another Saturday, June 28, 2008 @ 10:20PMThe exact mechanisms of how genes talk to other genes and change their behavior are being investigated, and recent results suggest that these processes could be important in engineering plants responsive to a variety of environmental conditions. Scientists have studied paramutations in maize and other plants and have identified some of the genes and mechanisms that operate in this epigenetic ...
Weighing the Costs of a Look Inside the Heart Saturday, June 28, 2008 @ 2:39PM Driven by financial incentives, many doctors are adopting CT scans before their benefits have been proved.
Dr. Kantor Saturday, June 28, 2008 @ 8:32AMDr. Kantor has not shared any health interests. Dr. Kantor has not shared any drug information.
Genome Communication Presented At Symposium On Maize Biology June 28, 2008 Saturday, June 28, 2008 @ 6:12AMIn the late 19th century Gregor Mendel used peas to show that one copy of a gene (allele) is inherited from the mother and one from the father.
S.D. stem cell efforts awarded $5 million total Saturday, June 28, 2008 @ 5:12AMSan Diego scientists were awarded $5 million in grants yesterday from a pool of $24 million approved by the California Institute for Regenerative Medicine. The money coming to San Diego includes $48,950 to the first commercial entity to receive institute funding: Novocell, the small company that is developing a method for turning human embryonic stem cells into insulin-producing cells that can ...
International Team Locates Key Player In Muscle Regeneration Saturday, June 28, 2008 @ 3:13AMA new understanding of the role played by the protein cdk9-55 in muscle regeneration and differentiation may lead to novel therapies to rebuild muscle tissue damaged by disease, injury and aging, according to researchers at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the University of Siena.
Personalizing Medicine: New Research Shows Potential Of Targeted Therapies For Cancer Friday, June 27, 2008 @ 10:21PMA new study shows the potential to pre-target the treatment of cancer cells -- bringing personalized medicine one step closer from the laboratory to patients. By combining new molecular imaging techniques with targeted therapy, pre-targeting offers cancer patients a more individualized treatment that can increase the effectiveness of therapies and minimize discomfort experienced during treatment.
Scientists Get $5M for Stem Cell Research Friday, June 27, 2008 @ 7:27PMA governing board with the state’s stem cell agency awarded $24 million in grants June 27 to help fund collaborative research on specific diseases and injuries and to further advances in new lines of human embryonic stem cells.
Stanford Researchers Get Stem Cell Grants for $5.6 Million Friday, June 27, 2008 @ 5:49PM STANFORD, Calif.----Stanford University School of Medicine researchers received approximately $5.6 million on June 27 from the California Institute for Regenerative Medicine in awards designed to support the creation of new pluripotent human stem cell lines.
Lack of Two Related Genes Disrupts Sleep Cycle Friday, June 27, 2008 @ 2:31PMTitle: Lack of Two Related Genes Disrupts Sleep Cycle Category: Health News Created: 6/27/2008 2:00:00 AM Last Editorial Review: 6/27/2008
Multiple Myeloma Research Consortium (MMRC) Expands Model to Fifteen Member Institutions Friday, June 27, 2008 @ 2:15PMThe Multiple Myeloma Research Consortium (MMRC) today announced the addition of two Member Institutions. The new institutions, Indiana University Simon Cancer Center in Indianapolis and the University of California, San Francisco (UCSF), were selected following a highly competitive Request for Application (RFA) process.
Multiple Myeloma Research Consortium (MMRC) Expands Model to Fifteen Member Institutions Friday, June 27, 2008 @ 1:55PMThe Multiple Myeloma Research Consortium (MMRC) today announced the addition of two Member Institutions.
International Team Locates Key Player in Muscle Regeneration Friday, June 27, 2008 @ 12:45PM A new understanding of the role played by the protein cdk9-55 in muscle regeneration and differentiation may lead to novel therapies to rebuild muscle tissue damaged by disease, injury and aging, according to researchers at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the University of Siena.
Glycology Announces 2 for 1 Special Friday, June 27, 2008 @ 10:41AMGlycology Announces 2 for 1 Special
Scientists Discover How An Injured Embryo Can Regenerate Itself Friday, June 27, 2008 @ 9:36AMScientists have developed a mathematical model to describe interactions that occur within genetic networks of an embryo, answering the age-old question of how half embryos are able to maintain their tissues and organs in the correct proportions despite being smaller than a normal sized embryo. Understanding the processes that govern embryonic cell development, may lead, in the future, to ...
Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual ... Friday, June 27, 2008 @ 4:00AM Using a high-output camera to film the back of the human eye, for the first time researchers have shown that a nutraceutical matrix can effectively remove cellular debris from the human eye that accumulates with advancing age and correlated this with significant improvement in visual acuity and night vision in an 80-year-old man.
My Pharmiweb.com Friday, June 27, 2008 @ 3:21AMBagnols-sur-CÃ¨ze, France â€“ June 26, 2008 â€“ Cisbio Bioassays, a member of IBA group and a global developer of HTRFÂ® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, today announced findings from its R&D collaboration with the Department of Molecular Pharmacology at the Institute of Functional Genomics (IGF) focused on the ...
Work On Laboratory Of The Future To Begin In Cambridge Friday, June 27, 2008 @ 3:14AMThe Medical Research Council has received Â£67 million towards a new building for the Laboratory of Molecular Biology from the Department for Innovation, Universities and Skills. The announcement was made by the Prime Minister, Gordon Brown during a summit to mark the beginning of celebrations for 60 years of the NHS.
City looking good: conference board Friday, June 27, 2008 @ 2:27AMThe worst appears to be over for Thunder Bay‘s manufacturing sector, according to a Conference Board of Canada report.